Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Walbrook PR is a public relations and investor relations consultancy primarily focused on serving Small Cap and AIM-listed companies. While it has a significant client base in the healthcare sector, it provides advisory services and is not itself a life sciences, biotech, pharmaceutical, or healthcare provider. The company was founded in 2009 by Paul McManus and offers financial PR, corporate communications, and IR advisory services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Walbrook PR.